text
"[""\nX. 대주주 등과의 거래내용\n가. 대주주 등에 대한 신용공여 등해당사항 없습니다.나. 대주주와의 자산양수도 및 영업거래 등보고서 작성기준일 현재 회사의 대주주 및 특수관계자 등에 대한 재화의 판매 또는 용역의 제공과 구입내역은 다음과 같습니다. 자세한 내역은 'III. 재무에 관한 사항 - 3. 연결재무제표 주석 - 23. 특수관계자 거래'를 참고하시기 바랍니다.[당분기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스 제공\n임대수익\n기타\n재고자산매입\n유무형자산 매입\n용역/서비스 비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n134,405\n39,249\n184,449\n966\n140,060\n-\n9,699,533\n5,854,796\n-\n관계기업\nImmplacate, Inc.\n-\n-\n-\n4,968\n-\n-\n-\n-\n-\nNurron Pharmaceuticals INC.\n-\n-\n-\n554,903\n-\n-\n-\n-\n-\n기타특수관계자\n대웅바이오(주)\n6,113,765\n713,923\n-\n1,212\n17,202,916\n-\n10,102,329\n8,336\n-\n(주)HR그룹\n-\n-\n-\n-\n-\n-\n600\n-\n-\n(주)아이디에스앤트러스트\n2,174\n8,091\n27,090\n-\n-\n149,300\n169,613\n-\n12,846\n(주)대웅경영개발원\n1,350\n-\n15,033\n182,485\n-\n-\n3,399\n-\n109,125\n(주)대웅생명과학\n-\n-\n-\n-\n-\n-\n-\n-\n86,367\n(주)대웅개발\n1,335\n7,025\n223,611\n-\n56,924\n-\n722,235\n4,805\n269,232\n(주)에스티에이치이솔루션\n-\n2,240\n-\n-\n-\n-\n5,403\n-\n27\n(주)대웅펫\n107,624\n-\n9,774\n29,881\n-\n-\n-\n10,209\n1,219\n(주)대웅테라퓨틱스\n129,521\n-\n-\n-\n-\n150,000\n-\n620,000\n-\n(주)대웅인베스트먼트\n-\n-\n2,226\n-\n-\n-\n-\n-\n-\n(주)알피스페이스\n-\n-\n-\n-\n117,324\n-\n-\n50\n284,367\n(주)알피바이오\n-\n-\n-\n-\n1,116,944\n-\n-\n-\n-\n(주)이지메디컴\n683,643\n-\n-\n-\n-\n-\n340,988\n206\n1,567,846\n(주)시지바이오\n770,647\n903,497\n37,800\n87,407\n2,550,951\n-\n104,559\n-\n174,110\n(주)바이오에이지\n233\n435\n-\n-\n11,700\n-\n1,596\n4,400\n345,760\n(주)디엔홀딩스\n-\n-\n99\n9,209\n-\n-\n-\n-\n-\n(주)디엔코스메틱스\n308,063\n5,168\n8,466\n624\n559,308\n-\n855\n2,272\n629,728\n(주)디엔컴퍼니\n5,238,746\n3,132\n120\n-\n-\n-\n66,982\n1,400\n-\n(주)엠서클\n12,905\n12,661\n-\n-\n75,334\n-\n1,970,668\n380\n1,171,296\n기타\n30,864\n46,951\n22,809\n-\n42,189\n-\n1,620,738\n1,062\n799,245\n합 \xa0계\n13,535,275\n1,742,372\n531,477\n871,655\n21,873,650\n299,300\n24,809,498\n6,507,916\n5,451,168\n[전분기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스 제공\n임대수익\n기타\n재고자산매입\n용역/서비스 비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n26,606\n44,535\n171,986\n9,027\n150,259\n8,966,231\n4,424,896\n8,855\n관계기업\n(주)엠디웰아이앤씨\n3,846\n448\n4,882\n-\n1,187\n22,488\n91\n28,557\n(주)바이오시네틱스\n-\n-\n-\n-\n-\n370\n-\n-\n(주)다나아데이터\r\n-\n-\n2,400\n-\n-\n-\n-\n-\nImmplacate, Inc.\n-\n-\n-\n4,718\n-\n-\n-\n-\n기타특수관계자\n대웅바이오(주)\n3,682,476\n44,186\n-\n-\n17,033,932\n7,200,013\n1,240\n-\n(주)아이디에스앤트러스트\n1,841\n9,570\n24,816\n6,018\n21,483\n238,668\n1,323\n1,019\n(주)대웅경영개발원\n300\n-\n41,604\n-\n1,519\n27,020\n35,676\n91,919\n(주)대웅생명과학\n-\n-\n-\n-\n-\n-\n-\n145,381\n(주)대웅이엔지\r\n2,130\n5,003\n677\n415\n1,823,046\n197,976\n65,230\n109,489\n(주)산웅개발\n132\n-\n-\n-\n22,487\n143,524\n-\n54,025\n(주)대웅개발\n-\n-\n191,649\n-\n10,905\n72,618\n-\n259,144\n(주)팜팩\n4,361\n-\n170\n-\n1,226,334\n-\n-\n-\n(주)에스티에이치이솔루션\r\n-\n1,641\n-\n-\n-\n-\n-\n2,337\n(주)대웅펫\n2,264\n-\n10,613\n-\n2,454\n-\n520\n109\n(주)대웅테라퓨틱스\r\n-\n-\n-\n-\n-\n-\n1,200,000\n-\n(주)디더블유메디팜\r\n-\n-\n-\n830\n268,314\n8,949\n79,900\n-\n(주)대웅인베스트먼트\n-\n-\n-\n10,715\n-\n-\n-\n-\n(주)알피스페이스\n-\n2,007\n-\n-\n86,676\n1,403\n50\n475,172\n(주)알피바이오\n-\n-\n-\n-\n1,609,032\n-\n-\n-\n(주)이지메디컴\n571,628\n990\n-\n203\n-\n246,018\n2,200\n1,271,221\n(주)시지바이오\n744,724\n31,562\n37,800\n-\n2,172,020\n73,220\n-\n23,982\n(주)바이오에이지\n50\n435\n-\n-\n9,000\n-\n9,600\n287,315\n(주)디엔홀딩스\n200\n1,479\n7,756\n7,300\n-\n-\n-\n-\n(주)디엔코스메틱스\n337,482\n4,174\n7,756\n1,579\n586,649\n-\n1,272\n571,490\n(주)디엔컴퍼니\n4,912,857\n3,567\n36,195\n-\n-\n197,668\n-\n-\n(주)엠서클\n6,582\n16,873\n29,253\n-\n34,012\n3,424,954\n1,159\n1,464,947\n기타\n186,206\n8,962\n18,486\n-\n-\n11,056\n1,862\n71,603\n합 \xa0계\n10,483,685\n175,432\n586,043\n40,805\n25,059,309\n20,832,176\n5,825,019\n4,866,565\n""]"
